Does Whole-Body Vibration Training Have a Concurrent Effect on Bone and Muscle Health? A Systematic Review and Meta-Analysis

Gerontology ◽  
2021 ◽  
pp. 1-11
Author(s):  
Christel Harijanto ◽  
Anthony Lim ◽  
Sara Vogrin ◽  
Gustavo Duque

Background: Aging results in musculoskeletal disorders, which are a leading cause of disability worldwide. While conventional nonpharmacological treatments have included interventions such as resistance exercise, there are subgroups of people who may be at risk of exercise-related injuries, for example, falls. Whole-body vibration (WBV) is an intervention that helps improve musculoskeletal function and is viable for those with limited mobility. Objectives: Whether WBV has a dual effect on bone and muscle conditions remains unknown. We aim to assess the evidence of the effects of WBV on bone and muscle parameters concurrently in older people. Methods: Under Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines, a systematic literature search was performed in MEDLINE, EMBASE, EMCARE, and the Cochrane Central Registry of Controlled Trials. The main outcomes were changes in bone and muscle parameters. Results: Our meta-analysis showed that WBV does not have significant synergistic effects on measured bone (bone mineral density [BMD] in the hip and lumbar spine) and muscle (lean muscle mass and sit-to-stand time) outcomes, compared to controls (i.e., no WBV included). Conclusion: While there were no significant results, the included studies are limited by small sample size and variable intervention protocols and follow-up periods. Further trials should endeavor to measure both bone and muscle outcomes concurrently with a longer follow-up time. Osteoporosis status in participants must also be considered as it is not yet possible to exclude that WBV may have a significant effect on BMD in people with known osteoporosis. WBV does not appear to simultaneously influence bone and muscle health in older people, and future research is required to establish a regimen that may lead to measurable clinical efficacy.

2011 ◽  
Vol 11 (1) ◽  
Author(s):  
Slavko Rogan ◽  
Roger Hilfiker ◽  
Kaspar Herren ◽  
Lorenz Radlinger ◽  
Eling D de Bruin

2012 ◽  
Vol 17 (2) ◽  
pp. 110-123 ◽  
Author(s):  
Ross D Pollock ◽  
Finbarr C Martin ◽  
Di J Newham

2019 ◽  
Vol 10 ◽  
Author(s):  
Matthieu Fischer ◽  
Thomas Vialleron ◽  
Guillaume Laffaye ◽  
Paul Fourcade ◽  
Tarek Hussein ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document